FDA busts myths of preventing and treating cancer by eating apricot kernels, herbs, and other ingredients
https://www.facingourrisk.org/XRAY/FDA-myth-busting
Full article: https://www.cnbc.com/2017/04/26/fda-warns-of-14-fraudulent-cancer-cure-companies.html
Maggie Fox (NBC News) writes about a new FDA report that warns of 14 "fraudulent” cancer products claiming to either cure or treat cancer (1). The companies that sell these products claim that many of them also prevent cancer, but are they safe or effective? (6/26/17)
Questions To Ask Your Health Care Provider
- What are my treatment options?
- Are there any supplements that I can take to help me prevent or treat my cancer?
- I'm taking herbal or dietary supplements, will these interfere with my treatment?
- I'm taking herbal or dietary supplements, are any of these harmal?
- I am having treatment side effects, are there any natural therapies that I can try?
- Can you refer me to an integrative medicine expert?
Open Clinical Trials
The following studies look at integrative medical care for people diagnosed with cancer:
Multiple cancer types
- NCT04917796: The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy. This study investigates whether electroacupuncture can improve peripheral neuropathy pain caused by chemotherapy in cancer survivors.
Breast cancer
- NCT04837820: Effect of Acupuncture on Memory and Thinking Difficulties after Breast Cancer. This study tests whether acupuncture can improve cognitive difficulties and insomnia for survivors of breast cancer.
Gynecologic cancer
- NCT05053230: A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Gynecologic Cancer. This study looks at whether the Integrative Medicine at Home program can reduce patients' symptoms (such as tiredness, pain or insomnia). This program offers virtual (online rather than in-person) group classes focusing on mind-body practice.
Prostate cancer
- NCT04519879: White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate Cancer. This phase II trial studies how well white button mushroom supplement reduces prostate-specific antigen (PSA) levels in patients with prostate cancer that has come back (recurrent) or has favorable risk and has not undergone any therapy (therapy-naive).
The following studies focus on nutrition and cancer prevention:
Colorectal cancer
- NCT05396846: My Best GI Eating Study. This study tests three diets in people who are overweight and who have an increased risk of colorectal cancer.
Visit our Featured Research Page and Research Search and Enroll Tool to find additional studies enrolling people with or at high risk for cancer.
The following studies look at the management of side effects:
Multiple cancers
- NCT02296450: Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments. This large study examines how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being.
- NCT05056077: Tools to be Fit. This quality-of-life study examines the best tools for helping cancer survivors improve their diet, and exercise for people with bladder, breast, colon, endometrial, kidney (renal cell carcinoma), ovarian, prostate or rectal cancer.
- NCT03996265: Bupropion in Reducing Cancer Related Fatigue in Cancer Survivors. This study tests how well the drug bupropion (Wellbutrin) reduces cancer-related fatigue for survivors.
Breast cancer
- NCT04586530: Telehealth and Memory Study (TAMS). This trial seeks to confirm the effectiveness of Memory and Attention Adaptation Training (TAMS), a cognitive-behavioral therapy as a treatment for chemotherapy-related cognitive dysfunction among breast cancer survivors.
- NCT02290834: Chemotherapy-induced cognitive and brain changes in older adults with breast cancer. This study investigates cognitive abilities and brain images before and after chemotherapy to identify people at risk for cognitive side effects and to better understand the effects of treatment on brain structure and function.
- NCT03879629: TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol (TACTIC). Breast cancer patients receiving Herceptin or other HER2-directed therapy are at risk of heart damage. This study looks at whether beta-blocker drugs could help prevent this from happening.
Colorectal cancer
- NCT05239338: Preserving Fertility After Colorectal Cancer Study (PREFACE). This study investigates the reproductive health and clinical outcomes among individuals ages 18 to 49 who are diagnosed with colorectal cancer.
- NCT06420726: Resistance Exercise and Creatine in Colorectal Cancer. This study assesses the feasibility of combining creatine supplementation with resistance training versus resistance training alone in colorectal cancer survivors.
Ovarian cancer
- NCT05047926: Prehabilitation for Advanced Ovarian Cancer Patients. This study tests whether structured activity for women undergoing neoadjuvant chemotherapy improves their physical state before surgery and thus improves outcomes.
Prostate cancer
- NCT03971591: Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors (MMF). This study looks at Men Moving Forward (MMF), a community-based lifestyle intervention that supports adherence to nutrition and physical activity guidelines to promote improved body composition and lessen the side effects of treatment.
- NCT05155501: Pelvic Fascia spARing Radical Prostatectomy TrIAL (PARTIAL). This clinical trial studies whether pelvic fascia-sparing radical prostatectomy has similar cancer control and sexual function outcomes and significantly better urinary function, less penile deformity and inguinal hernia risks as compared to radical prostatectomy.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.